These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 39122202

  • 1. The pipeline of immunomodulatory therapies in polymyalgia rheumatica and giant cell arteritis: A systematic review of clinical trials.
    Kawka L, Chevet B, Arnaud L, Becker G, Carvajal Alegria G, Felten R.
    Autoimmun Rev; 2024; 23(7-8):103590. PubMed ID: 39122202
    [Abstract] [Full Text] [Related]

  • 2. Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.
    Dejaco C, Brouwer E, Mason JC, Buttgereit F, Matteson EL, Dasgupta B.
    Nat Rev Rheumatol; 2017 Oct; 13(10):578-592. PubMed ID: 28905861
    [Abstract] [Full Text] [Related]

  • 3. Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis.
    Man-Ger Sun M, Pope JE.
    Best Pract Res Clin Rheumatol; 2022 Dec; 36(4):101822. PubMed ID: 36907732
    [Abstract] [Full Text] [Related]

  • 4. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.
    Gonzalez-Gay MA, Garcia-Porrua C, Miranda-Filloy JA, Martin J.
    Drugs Aging; 2006 Dec; 23(8):627-49. PubMed ID: 16964987
    [Abstract] [Full Text] [Related]

  • 5. Polymyalgia rheumatica and giant cell arteritis induced by immune checkpoint inhibitors: A systematic literature review highlighting differences from the idiopathic forms.
    Hysa E, Casabella A, Gotelli E, Campitiello R, Schenone C, Genova C, Tanda ET, Sulli A, Smith V, Cimmino MA, Paolino S, Cutolo M.
    Autoimmun Rev; 2024 Dec; 23(7-8):103589. PubMed ID: 39117006
    [Abstract] [Full Text] [Related]

  • 6. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F, Dejaco C, Matteson EL, Dasgupta B.
    JAMA; 2016 Jun 14; 315(22):2442-58. PubMed ID: 27299619
    [Abstract] [Full Text] [Related]

  • 7. Review of phase 2/3 trials in polymyalgia rheumatica and giant cell arteritis.
    Nageswaran P, Ahmed S, Tahir H.
    Expert Opin Emerg Drugs; 2024 Mar 14; 29(1):5-17. PubMed ID: 38180809
    [Abstract] [Full Text] [Related]

  • 8. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
    Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A.
    Rheumatol Int; 2018 Apr 14; 38(4):569-577. PubMed ID: 29124397
    [Abstract] [Full Text] [Related]

  • 9. Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series.
    Diamantopoulos AP, Hetland H, Myklebust G.
    Biomed Res Int; 2013 Apr 14; 2013():120638. PubMed ID: 24106691
    [Abstract] [Full Text] [Related]

  • 10. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
    Askling J, Klareskog L, Hjalgrim H, Baecklund E, Björkholm M, Ekbom A.
    Ann Rheum Dis; 2005 Dec 14; 64(12):1765-8. PubMed ID: 15843445
    [Abstract] [Full Text] [Related]

  • 11. Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica.
    El Chami S, Springer JM.
    Rheum Dis Clin North Am; 2022 May 14; 48(2):493-506. PubMed ID: 35400374
    [Abstract] [Full Text] [Related]

  • 12. [Polymyalgia rheumatica and Giant Cell Arteritis - Update on Diagnosis and Therapy].
    Becker M.
    Praxis (Bern 1994); 2020 May 14; 109(5):347-354. PubMed ID: 32233763
    [Abstract] [Full Text] [Related]

  • 13. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
    Lally L, Spiera R.
    Best Pract Res Clin Rheumatol; 2018 Dec 14; 32(6):803-812. PubMed ID: 31427056
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series.
    Adizie T, Christidis D, Dharmapaliah C, Borg F, Dasgupta B.
    Int J Clin Pract; 2012 Sep 14; 66(9):906-9. PubMed ID: 22897467
    [Abstract] [Full Text] [Related]

  • 15. Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives.
    Ferraccioli GF, Di Poi E, Damato R.
    Clin Exp Rheumatol; 2000 Sep 14; 18(4 Suppl 20):S58-60. PubMed ID: 10948766
    [Abstract] [Full Text] [Related]

  • 16. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J, Warrington KJ.
    Drugs Aging; 2011 Aug 01; 28(8):651-66. PubMed ID: 21812500
    [Abstract] [Full Text] [Related]

  • 17. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM, Blanco R, Fito C, Pacheco MJ, Delgado-Rodriguez M, Rodriguez-Valverde V.
    Semin Arthritis Rheum; 2001 Feb 01; 30(4):257-71. PubMed ID: 11182026
    [Abstract] [Full Text] [Related]

  • 18. The 2023 pipeline of disease-modifying antirheumatic drugs (DMARDs) in clinical development for spondyloarthritis (including psoriatic arthritis): a systematic review of trials.
    Denis A, Sztejkowski C, Arnaud L, Becker G, Felten R.
    RMD Open; 2023 Jul 01; 9(3):. PubMed ID: 37507210
    [Abstract] [Full Text] [Related]

  • 19. Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS, Abdulahad WH, Chalan P, Rutgers A, Horst G, Huitema MG, Roffel MP, Roozendaal C, Kluin PM, Bos NA, Boots AM, Brouwer E.
    Arthritis Rheumatol; 2014 Jul 01; 66(7):1927-38. PubMed ID: 24623536
    [Abstract] [Full Text] [Related]

  • 20. Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
    De Miguel E, Karalilova R, Macchioni P, Ponte C, Conticini E, Cowley S, Tomelleri A, Monti S, Monjo I, Batalov Z, Klinowski G, Falsetti P, Kane DJ, Campochiaro C, Hočevar A.
    Ann Rheum Dis; 2024 Feb 15; 83(3):335-341. PubMed ID: 37932008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.